Meridian Bioscience Inc. | Income Statement
Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
188,686.00
188,832.00
194,830.00
196,082.00
200,771.00
213,571
Cost of Goods Sold (COGS) incl. D&A
67,642.00
71,589.00
72,948.00
68,295.00
75,938.00
83,110
Gross Income
121,044.00
117,243.00
121,882.00
127,787.00
124,833.00
130,461
SG&A Expense
63,730.00
64,851.00
65,822.00
74,251.00
80,061.00
85,826
EBIT
57,314.00
52,392.00
56,060.00
-
44,772.00
44,635
Unusual Expense
-
-
-
2,158.00
7,390.00
13,051
Non Operating Income/Expense
4.00
309.00
1,020.00
96.00
518.00
102
Interest Expense
-
-
-
897.00
1,642.00
1,520
Pretax Income
57,362.00
52,108.00
55,063.00
50,644.00
36,429.00
30,380
Income Tax
19,330.00
17,365.00
19,523.00
18,415.00
14,872.00
6,531
Consolidated Net Income
38,032.00
34,743.00
35,540.00
32,229.00
21,557.00
23,849
Net Income
38,032.00
34,743.00
35,540.00
32,229.00
21,557.00
23,849
Net Income After Extraordinaries
38,032.00
34,743.00
35,540.00
32,229.00
21,557.00
23,849
Net Income Available to Common
38,032.00
34,743.00
35,540.00
32,229.00
21,557.00
23,849
EPS (Basic)
0.91
0.83
0.85
0.76
0.51
0.56
Basic Shares Outstanding
41,226.00
41,455.00
41,659.00
42,010.00
42,188.00
42,325
EPS (Diluted)
0.91
0.83
0.85
0.76
0.51
0.56
Diluted Shares Outstanding
41,895.00
41,913.00
42,012.00
42,393.00
42,571.00
42,754
EBITDA
64,466.00
57,954.00
62,669.00
61,254.00
53,862.00
53,323
Non-Operating Interest Income
44.00
25.00
23.00
67.00
171.00
418
About Meridian Bioscience
View Profile
